Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease

CONCLUSIONS: When considering all urinary abnormalities together, this study demonstrates that use of preventive pharmacological therapy is associated with a lower risk of clinically significant recurrent episodes of urinary stone disease in the 12-36 month timeframe following urine collection, though only the association with use of alkali therapy for hypocitraturia was significant when individual abnormalities were examined.PMID:38345854 | DOI:10.2215/CJN.0000000000000428

Source: Clinical Journal of the American Society of Nephrology : CJASN - February 12, 2024 Category: Urology & Nephrology Authors: Kumaran Arivoli Autumn N Valicevic Mary K Oerline Ryan S Hsi Sanjeevkumar R Patel John M Hollingsworth Vahakn B Shahinian Source Type: research